Literature DB >> 6476798

Cerebellar atrophy following phenytoin intoxication.

O Lindvall, B Nilsson.   

Abstract

Cerebellar degeneration has been demonstrated in several patients receiving phenytoin therapy. In most cases it has been unclear, however, whether the degeneration was caused by the drug per se or by other mechanisms known to lead to cerebellar damage. We describe a patient who developed a marked cerebellar atrophy, demonstrated on computed tomographic scan, following an episode of acute, severe phenytoin intoxication. The patient received phenytoin prophylactically for 2 1/2 months after an uncomplicated subarachnoid hemorrhage and was in good health when the treatment was started. He has never had seizures, and no other possible cause of chronic cerebellar changes is known. The initially severe clinical signs of cerebellar dysfunction have subsided slowly. We conclude that phenytoin can directly cause cerebellar degeneration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476798     DOI: 10.1002/ana.410160218

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

Review 1.  Drug-induced cerebellar ataxia: a systematic review.

Authors:  J van Gaalen; F G Kerstens; R P P W M Maas; L Härmark; B P C van de Warrenburg
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

2.  Prnp gene and cerebellum volume in patients with refractory mesial temporal lobe epilepsy.

Authors:  Michelle N Valadão; Erica R Coimbra; Michele C Landemberger; Tonicarlo R Velasco; Vera C Terra; Lauro Wichert-Ana; Veriano Alexandre; David Araújo; Ricardo Guarnieri; Vilma R Martins; Antônio Carlos Santos; Américo C Sakamoto; Roger Walz
Journal:  Neurol Sci       Date:  2013-10-05       Impact factor: 3.307

3.  The nature and extent of cerebellar atrophy in chronic temporal lobe epilepsy.

Authors:  Temitayo O Oyegbile; Katherine Bayless; Kevin Dabbs; Jana Jones; Paul Rutecki; Ronald Pierson; Michael Seidenberg; Bruce Hermann
Journal:  Epilepsia       Date:  2011-01-26       Impact factor: 5.864

Review 4.  Clinical features and management of poisoning due to phenytoin.

Authors:  J R Larsen; L S Larsen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

5.  Cerebellar injury due to phenytoin. Identification and evolution of Purkinje cell axonal swellings in deep cerebellar nuclei of mice.

Authors:  R Kiefer; R Knoth; J Anagnostopoulos; B Volk
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 6.  Phenytoin poisoning.

Authors:  Simon Craig
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

7.  Voxel based morphometry of grey matter abnormalities in patients with medically intractable temporal lobe epilepsy: effects of side of seizure onset and epilepsy duration.

Authors:  S S Keller; U C Wieshmann; C E Mackay; C E Denby; J Webb; N Roberts
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

8.  Deformation-based morphometry of prospective neurodevelopmental changes in new onset paediatric epilepsy.

Authors:  Duygu Tosun; Kevin Dabbs; Rochelle Caplan; Prabha Siddarth; Arthur Toga; Michael Seidenberg; Bruce Hermann
Journal:  Brain       Date:  2011-03-11       Impact factor: 13.501

9.  Laparoscopic Chromopertubation, Myomectomy with Opening of the Uterine Cavity and Hysteroscopy during the Early Implantation Phase of an Undetected Pregnancy: Delivery of a Child with a Complex Brain Malformation.

Authors:  C Mann; K Karl; B Ertl-Wagner; H Weigand; C J Thaler
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-08       Impact factor: 2.915

Review 10.  The long-term safety of antiepileptic drugs.

Authors:  Athanasios Gaitatzis; Josemir W Sander
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.